Abstract
Some shifts in the gut microbiota composition and its metabolic fingerprints have been associated to Sleeve gastrectomy (SG) and Roux-en-Y Gastric Bypass (RYGB). So far, plasma bile acids have been associated with post-operative glucose improvement and weight loss, but nothing is known about their metabolism in the gut lumen. As bile acids are physiologically transformed by the microbiota into various species, the aim of this work was to study how SG and RYGB-associated dysbiosis impact the bioconversion of bile acids in the intestinal lumen. Comparing SHAM (n = 9) with our validated rat models of SG (n = 5) and RYGB (n = 6), we quantified luminal bile acids along the gut and found that the metabolic transformation of bile acids (deconjugation, dehydroxylation, and epimerization) is not different from the duodenum to the colon. However, in the cecum where the biotransformation mainly takes place, we observed deep alterations of the microbiota composition, which were specific of each type of surgery. In conclusion, despite specific dysbiosis after surgery, the bile acids metabolism in the gut lumen is highly preserved, suggesting that a resilience of the gut microbiota occurs after these procedures.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout


References
Kohli R, et al. Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids. J Clin Endocrinol Metab. 2013;98:E708–12.
Ahmad NN, Pfalzer A, Kaplan LM. Roux-en-Y gastric bypass normalizes the blunted postprandial bile acid excursion associated with obesity. Int J Obes. 2013;37:1553–9.
Pournaras DJ, et al. The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. Endocrinology. 2012;153:3613–9.
Penney NC, Kinross J, Newton RC, Purkayastha S. The role of bile acids in reducing the metabolic complications of obesity after bariatric surgery: a systematic review. Int J Obes. 2015;39:1565–74.
Gralka E, et al. Metabolomic fingerprint of severe obesity is dynamically affected by bariatric surgery in a procedure-dependent manner. Am J Clin Nutr. 2015;102:1313–22.
Murphy R. Differential adaptation of human gut microbiota to weight loss and diabetes remission achieved by gastric bypass versus sleeve gastrectomy, EASD meeting, Stockholm, Sweden. 2015.
Chávez-Talavera O, et al. Roux-en-Y gastric bypass increases systemic but not portal bile acid concentrations by decreasing hepatic bile acid uptake in minipigs. Int J Obes. 2017;41:664–8.
Hofmann AF. Bile acids: the good, the bad, and the ugly. News Physiol Sci. 1999;14:24–9.
Ridlon JM, Kang D-J, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. J Lipid Res. 2006;47:241–59.
Arapis K, et al. Remodeling of the residual gastric mucosa after roux-en-y gastric bypass or vertical sleeve gastrectomy in diet-induced obese rats. PLoS ONE. 2015;10:e0121414.
Liguori G, et al. Fungal dysbiosis in mucosa-associated microbiota of Crohn’s disease patients. J Crohns Colitis. 2015;10:296–305.
Schmieder R, Edwards R. Quality control and preprocessing of metagenomic datasets. Bioinformatics. 2011;27:863–4.
Magoč T, Salzberg SL. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics. 2011;27:2957–63.
Sacquet EC, et al. Bacterial formation of omega-muricholic acid in rats. Appl Environ Microbiol. 1979;37:1127–31.
Risstad H, et al. Bile acid profiles over 5 years after gastric bypass and duodenal switch: results from a randomized clinical trial. Surg Obes Relat Dis. 2017;13:1544–53.
Fouladi F, Mitchell JE, Wonderlich JA, Steffen KJ. The contributing role of bile acids to metabolic improvements after obesity and metabolic surgery. Obes Surg. 2016;26:2492–502.
Caporaso JG, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7:335–6.
Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics. 2010;26:2460–1.
McDonald D, et al. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J. 2012;6:610–8.
Hirano S, Masuda N, Oda H, Mukai H. Transformation of bile acids by Clostridium perfringens. Appl Environ Microbiol. 1981;42:394–9.
Duboc H, et al. Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases. Gut. 2013;62:531–9.
Ussar S, et al. Interactions between gut microbiota, host genetics and diet modulate the predisposition to obesity and metabolic syndrome. Cell Metab. 2015;22:516–30.
Segata N, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12:R60.
Acknowledgements
This work was supported by the FARE grant from the “Société Nationale Francaise d’Hepato-Gastro-Entérologie”.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Harry Sokol and André Bado are co-senior authors.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Duboc, H., Nguyen, C.C., Cavin, JB. et al. Roux-en-Y Gastric-Bypass and sleeve gastrectomy induces specific shifts of the gut microbiota without altering the metabolism of bile acids in the intestinal lumen. Int J Obes 43, 428–431 (2019). https://doi.org/10.1038/s41366-018-0015-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41366-018-0015-3
This article is cited by
-
PBPK modeling of CYP3A and P-gp substrates to predict drug–drug interactions in patients undergoing Roux-en-Y gastric bypass surgery
Journal of Pharmacokinetics and Pharmacodynamics (2020)
-
Peri-operative, intravenous clindamycin may improve the resolution rate of hypertension after Roux-en-Y gastric bypass in morbidly obese patients
Surgical Endoscopy (2019)
-
Impact of bariatric surgery on type 2 diabetes: contribution of inflammation and gut microbiome?
Seminars in Immunopathology (2019)
-
Gut Microbiota Dysbiosis in Human Obesity: Impact of Bariatric Surgery
Current Obesity Reports (2019)
-
Connection between gut microbiome and the development of obesity
European Journal of Clinical Microbiology & Infectious Diseases (2019)